Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Gains from Investment Securities (2019 - 2026)

InMed Pharmaceuticals has reported Gains from Investment Securities over the past 5 years, most recently at $138150.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 121.34% year-over-year to $138150.0; the TTM value through Dec 2025 reached $138150.0, up 121.34%, while the annual FY2025 figure was $61410.0, 82.11% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $138150.0 at InMed Pharmaceuticals, up from $60356.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $580400.0 in Q1 2024 and troughed at -$973284.0 in Q2 2024.
  • A 5-year average of $12494.0 and a median of $33578.0 in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: crashed 92.51% in 2023 and later surged 36682.51% in 2024.
  • Year by year, Gains from Investment Securities stood at -$6030.0 in 2021, then tumbled by 104.1% to -$12307.0 in 2022, then surged by 111.03% to $1357.0 in 2023, then skyrocketed by 4499.56% to $62416.0 in 2024, then skyrocketed by 121.34% to $138150.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for INM at $138150.0 in Q4 2025, $60356.0 in Q3 2025, and $61864.0 in Q1 2025.